Literature DB >> 20233114

Psychotic features associated with multiple sclerosis.

Mary H Kosmidis1, Maria Giannakou, Lambros Messinis, Panagiotis Papathanasopoulos.   

Abstract

Although once considered rare, several more recent investigations have been published describing psychotic features in multiple sclerosis (MS). The association between the two conditions, however, remains unclear. Large-scale hospital-based, epidemiological and case studies have suggested a relationship between psychosis and MS through demonstrating their higher than chance co-occurrence, their temporal relationship, and their association with particular structural abnormalities in the brain (i.e., periventricular white matter and temporal demyelination). The etiology of psychosis in MS has also not been explained adequately. Regional demyelination and the use of corticosteroids have been implicated, yet their mechanisms of action have not been elucidated. The present review addresses what is known at this point in time regarding the occurrence of psychosis in the context of MS, the data regarding possible etiological factors, and the implications of these data and suggestions regarding diagnosis and treatment. Future research should explore the underlying pathophysiology of psychosis and multiple sclerosis to further our understanding of the central nervous system disease process. This research could help determine the features which would guide clinicians in identifying patients at risk of developing psychosis in the context of MS, as well as propose the optimal pharmacological intervention.

Entities:  

Mesh:

Year:  2010        PMID: 20233114     DOI: 10.3109/09540261003589612

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  12 in total

1.  Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.

Authors:  Jinling Zhang; Liu Yang; Zeman Fang; Jiming Kong; Qingjun Huang; Haiyun Xu
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-01       Impact factor: 4.147

2.  Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange.

Authors:  Tereza Gabelić; Ivan Adamec; Anamarija Mrđen; Milan Radoš; Vesna V Brinar; Mario Habek
Journal:  Neurol Sci       Date:  2011-07-28       Impact factor: 3.307

3.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

Review 4.  Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder.

Authors:  Shingo Miyata; Tsuyoshi Hattori; Shoko Shimizu; Akira Ito; Masaya Tohyama
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  The spectrum of psychosis in multiple sclerosis: a clinical case series.

Authors:  Thomas G Gilberthorpe; Kara E O'Connell; Alison Carolan; Eli Silber; Peter A Brex; Naomi A Sibtain; Anthony S David
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-01       Impact factor: 2.570

6.  Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center.

Authors:  Lisa A S Walker; Courtney Gardner; Mark S Freedman; Heather MacLean; Carolina Rush; Marjorie Bowman
Journal:  Int J MS Care       Date:  2019 Nov-Dec

7.  DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes.

Authors:  Tsuyoshi Hattori; Shoko Shimizu; Yoshihisa Koyama; Hisayo Emoto; Yuji Matsumoto; Natsuko Kumamoto; Kohei Yamada; Hironori Takamura; Shinsuke Matsuzaki; Taiichi Katayama; Masaya Tohyama; Akira Ito
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

Review 8.  Epigenetic Drugs for Multiple Sclerosis.

Authors:  Jacob Peedicayil
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 9.  Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570

Review 10.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.